Segments in this Video

MDS Patients (01:35)


Myelodysplastic syndromes are a group of little-known conditions where the bone marrow does not produce enough normal blood cells for proper body function. New therapies are improving outcomes for older patients. Dr. McFarland outlines the topics of this film.

Myelodysplastic Syndromes Diagnosis (03:19)

MDS is a group of diseases with various subtypes that have many differences; experts believe MDS is under diagnosed. Margaret Skinner discusses her high risk MDS diagnosis. Drs. Steensma and Giagounidis explain MDS functionality.

MDS is a Cancer (02:13)

Heinz Lehmann recalls his MDS symptoms. More than 15,000 people are diagnosed with MDS every year. More than 80% of cases occur in people over the age of 60. An expert discusses possible causes; age is the most common risk factor.

What Does Myelodysplastic Syndromes Mean? (02:47)

Learn the definition of MDS and its symptoms. Approximately one third of cases can progress to a form of leukemia. The International Prognostic Scoring System (IPPS) identifies progression possibility. Experts discuss treating high and low risk MDS with supportive and active therapy.

Curing Myelodysplastic Syndromes (01:26)

The only way to potentially cure MDS is with an allogeneic stem cell transplant. Heinz Lehmann's transplant allows him to live a healthy life. Most patients are not candidates for transplants and use medication for treatment.

Myelodysplastic Syndromes Communication (04:17)

Luig Cellai recalls being too fatigued to walk the streets of Florence, Italy and receiving an MDS diagnosis. See a list of important doctor/patient communication topics. Learn the standard treatments for MDS. MDS-specific agents can provide better treatment options.

MDS FYI (00:56)

Treating MDS can dominate patient lives. See a brief preview of the upcoming segment. The term "myelodysplastic syndromes" has been used since the late 1970s.

Supportive Care (04:45)

Supportive care is part of most MDS treatment plans. Clear communication and MDS education is important for patients. Margaret Skinner shares her feelings about her MDS diagnosis and her clinical trial treatment. Experts discuss the importance of clinical trials.

Managing MDS (02:14)

Dr. Giagounidis discusses the importance of MDS patient education for disease management. The immediate goal of treatment is to get patients into remission. Dr. Steensma explains remission. Luig Cellai is excited about becoming a grandfather.

Credits: New Ways to Manage MDS (00:35)

Credits: New Ways to Manage MDS

For additional digital leasing and purchase options contact a media consultant at 800-257-5126
(press option 3) or

New Ways to Manage MDS

DVD (Chaptered) Price: $129.95
DVD + 3-Year Streaming Price: $194.93
3-Year Streaming Price: $129.95



Myelodysplastic syndromes, or MDS, are a group of diseases of the blood cells and bone marrow that can result in anemia and increased infections, and in some cases, even progress to leukemia. The only way to cure MDS is with a stem cell transplant, but since patients are usually elderly and too frail to withstand the procedure, those most in need of treatment have not been able to avail themselves of it. This program goes to Boston, Dusseldorf, and Florence to see how medical breakthroughs are now improving outcomes for people with MDS—even those who are in their 90s. (24 minutes)

Length: 25 minutes

Item#: BVL53737

ISBN: 978-1-61753-998-5

Copyright date: ©2013

Closed Captioned

Performance Rights

Prices include public performance rights.